Quantification of protein interactions and solution transport using high-density GMR sensor arrays

Nature Nanotechnology

Volumn 6, Issue 5, 2011, Pages 314-320

  Gaster, Richard S ^a,b   Xu, Liang ^a   Han, Shu Jen ^c   Wilson, Robert J ^a   Hall, Drew A ^a   Osterfeld, Sebastian J ^d   Yu, Heng ^d   Wang, Shan X ^a  

^a Stanford University   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c IBM T J WATSON RESEARCH CENTER   (United States)

^d MagArray Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KINETICS; SURFACE PLASMON RESONANCE;

ANTIBODY-ANTIGEN; BINDING KINETICS; DRUG DEVELOPMENT; HIGH-THROUGHPUT ANALYSIS; NON-SPECIFIC BINDING; PROTEIN INTERACTION; PROTEOMIC ANALYSIS; SPATIAL AND TEMPORAL RESOLUTIONS;

ANTIBODIES;

ARTICLE; BINDING KINETICS; BIOSENSOR; NANOSENSOR; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION;

EID: 79955870892     PISSN: 17483387     EISSN: 17483395     Source Type: Journal    
DOI: 10.1038/nnano.2011.45     Document Type: Article

References (54)

1. Schena, M., Shalon, D., Davis, R. W. & Brown, P. O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270, 467-470 (1995).
2. MacBeath, G. & Schreiber, S. L. Printing proteins as microarrays for high-throughput function determination. Science 289, 1760-1763 (2000).
3. Zheng, G., Patolsky, F., Cui, Y., Wang, W. U. & Lieber, C. M. Multiplexed electrical detection of cancer markers with nanowire sensor arrays. Nature Biotechnol. 23, 1294-1301 (2005). (Pubitemid 41486858)
4. James, L. C. & Tawfik, D. S. Structure and kinetics of a transient antibody binding intermediate reveal a kinetic discrimination mechanism in antigen recognition. Proc. Natl Acad. Sci. USA 102, 12730-12735 (2005). (Pubitemid 41279434)
5. LaBaer, J. & Ramachandran, N. Protein microarrays as tools for functional proteomics. Curr. Opin. Chem. Biol. 9, 14-19 (2005). (Pubitemid 40208619)
6. Park, J. et al. A highly sensitive and selective diagnostic assay based on virus nanoparticles. Nature Nanotech. 4, 259-264 (2009).
7. Hudson, P. J. & Souriau, C. Engineered antibodies. Nature Med. 9, 129-134 (2003). (Pubitemid 36098274)
8. Schrama, D., Reisfeld, R. A. & Becker, J. C. Antibody targeted drugs as cancer therapeutics. Nature Rev. Drug Discov. 5, 147-159 (2006).
9. Sinensky, A. K. & Belcher, A. M. Label-free and high-resolution protein//DNA nanoarray analysis using kelvin probe force microscopy. Nature Nanotech. 2, 653-659 (2007). (Pubitemid 47525188)
10. Haab, B. B., Dunham, M. J. & Brown, P. O. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol. 2, research0004.1-research0004.13 (2001).
11. Wilson, W. D. Analyzing biomolecular interactions. Science 295, 2103-2105 (2002). (Pubitemid 34229477)
12. Bornhop, D. J. et al. Free-solution, label-free molecular interactions studied by back-scattering interferometry. Science 317, 1732-1736 (2007). (Pubitemid 47461834)
13. Stern, E. et al. Label-free biomarker detection from whole blood. Nature Nanotech. 5, 138-142 (2010).
14. Squires, T. M., Messinger, R. J. & Manalis, S. R. Making it stick: convection, reaction and diffusion in surface-based biosensors. Nature Biotechnol. 26, 417-426 (2008). (Pubitemid 351501812)
15. Ramachandran, N. et al. Self-assembling protein microarrays. Science 305, 86-90 (2004). (Pubitemid 38869377)
16. Patolsky, F. et al. Electrical detection of single viruses. Proc. Natl Acad. Sci. USA 101, 14017-14022 (2004). (Pubitemid 39305021)
17. Patolsky, F. & Lieber, C. M. Nanowire nanosensors. Materials Today 8, 20-28 (2005). (Pubitemid 40352462)
18. Berg, H. & Purcell, E. Physics of chemoreception. Biophys. J. 20:193-219 (1977). (Pubitemid 8220672)
19. Berg, O. G. & von Hippel, P. H. Diffusion-controlled macromolecular interactions. Annu. Rev. Biophys. Biophys. Chem. 14, 131-160 (1985).
20. Stenberg, M. & Nygren, H. Kinetics of antigen-antibody reactions at solid-liquid interfaces. J. Immunol. Methods 113, 3-15 (1988).
21. Waite, B. A. & Stewart, J. D. An idealized dynamical model of simple diffusional interactions between macromolecules and between macromolecules and surfaces. Math. Biosci. 114, 173-213 (1993).
22. Sheehan, P. E. & Whitman, L. J. Detection limits for nanoscale biosensors. Nano Lett. 5, 803-807 (2005).
23. Swift, J. L. & Cramb, D. T. Nanoparticles as fluorescence labels: is size all that matters? Biophys. J. 95, 865-876 (2008).
24. Röcker, C., Pötzl, M., Zhang, F., Parak, W. J. & Nienhaus, G. U. A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. Nature Nanotech. 4, 577-580 (2009).
25. Osterfeld, S. J. et al. Multiplex protein assays based on real-time magnetic nanotag sensing. Proc. Natl Acad. Sci. USA 105, 20637-20640 (2008).
26. Gaster, R. S. et al. Matrix-insensitive protein assays push the limits of biosensors in medicine. Nature Med. 15, 1327-1332 (2009).
27. Gaster, R. S., Hall, D. A. & Wang, S. X. nanoLAB: an ultraportable, handheld diagnostic laboratory for global health. Lab Chip 11, 950-956 (2011).
28. Baibich, M. N. et al. Giant magnetoresistance of (001)Fe/(001)Cr magnetic superlattices. Phys. Rev. Lett. 61, 2472-2475 (1988).
29. Barnas, J., Fuss, A., Camley, R., Grünberg, P. & Zinn, W. Novel magnetoresistance effect in layered magnetic structures: theory and experiment. Phys. Rev. B 42, 8110-8120 (1990).
30. Prinz, G. A. Magnetoelectronics. Science 282, 1660-1663 (1998). (Pubitemid 28549273)
31. Wolf, S. A. et al. Spintronics: a spin-based electronics vision for the future. Science 294, 1488-1495 (2001). (Pubitemid 33063913)
32. Mulvaney, S., Myers, K., Sheehan, P. & Whitman, L. Attomolar protein detection in complex sample matrices with semi-homogeneous fluidic force discrimination assays. Biosens. Bioelectron. 24, 1109-1115 (2009).
33. Baselt, D. R. et al. A biosensor based on magnetoresistance technology. Biosens. Bioelectron. 13, 731-739 (1998). (Pubitemid 28494278)
34. Sandhu, A. Biosensing: new probes offer much faster results. Nature Nanotech. 2, 746-748 (2007). (Pubitemid 350223356)
35. Koets, M., van der Wijk, T., van Eemeren, J., van Amerongen, A. & Prins, M. Rapid DNA multi-analyte immunoassay on a magneto-resistance biosensor. Biosens. Bioelectron. 24, 1893-1898 (2009).
36. Xu, L. et al. Giant magnetoresistive biochip for DNA detection and HPV genotyping. Biosens. Bioelectron. 24, 99-103 (2008).
37. Koh, A. L. & Sinclair, R. TEM studies of iron oxide nanoparticles for cell labeling and magnetic separation. Technical Proceedings of the 2007 NSTI Nanotechnology Conference and Trade Show, 101-104 (2007). (Pubitemid 47273429)
38. De Palma, R. et al. Magnetic particles as labels in bioassays: interactions between a biotinylated gold substrate and streptavidin magnetic particles. J. Phys. Chem. C 111, 12227-12235 (2007). (Pubitemid 47387775)
39. Malmqvist, M. Biospecific interaction analysis using biosensor technology. Nature 361, 186-187 (1993).
40. Katsamba, P. S. et al. Kinetic analysis of a high-affinity antibody/antigen interaction performed by multiple Biacore users. Anal. Biochem. 352, 208-221 (2006).
41. Lausted, C., Hu, Z. & Hood, L. Quantitative serum proteomics from surface plasmon resonance imaging. Mol. Cell Proteomics 7, 2464-2474 (2008).
42. Rich, R. L. & Myszka, D. G. Higher-throughput, label-free, real-time molecular interaction analysis. Anal. Biochem. 361, 1-6 (2007). (Pubitemid 46026999)
43. Campbell, C. T. & Kim, G. SPR microscopy and its applications to high-throughput analyses of biomolecular binding events and their kinetics. Biomaterials 28, 2380-2392 (2007). (Pubitemid 46389403)
44. Wang, S. & Guanxiong Li. Advances in giant magnetoresistance biosensors with magnetic nanoparticle tags: review and outlook. IEEE Trans. Magnetics 44, 1687-1702 (2008).
45. Myszka, D. G., He, X., Dembo, M., Morton, T. A. & Goldstein, B. Extending the range of rate constants available from BIACORE: interpreting mass transport-influenced binding data. Biophys. J 75, 583-594 (1998). (Pubitemid 28357501)
46. Reichert, J. M. & Valge-Archer, V. E. Development trends for monoclonal antibody cancer therapeutics. Nature Rev. Drug Discov. 6, 349-356 (2007). (Pubitemid 46696550)
47. Willett, C. G. et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nature Med. 10, 145-147 (2004). (Pubitemid 38524883)
48. Anderson, N. L. The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum. Clin. Chem. 56, 177-185 (2010).
49. Cai, W. et al. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett. 6, 669-676 (2006).
50. Gaster, R. S., Hall, D. A. & Wang, S. X. Autoassembly protein arrays for analyzing antibody cross-reactivity. Nano Lett. doi:10.1021/nl1026056 (2010).
51. Srisa-Art, M., Dyson, E. C., deMello, A. J. & Edel, J. B. Monitoring of real-time streptavidin-biotin binding kinetics using droplet microfluidics. Anal. Chem. 80, 7063-7067 (2008).
52. Barbosa, M. D., Chamberlain, A. K. & Desjarlais, J. R. Optimized proteins that target Ep-CAM. US patent 7,557,190 (2009), available via http://go.nature.com/lbOXuD
53. Hefta, L. J. F., Neumaier, M. & Shively, J. E. Kinetic and affinity constants of epitope specific anti-carcinoembryonic antigen (CEA) monoclonal antibodies for CEA and engineered CEA domain constructs. Immunotechnology 4, 49-57 (1998). (Pubitemid 28302184)
54. Chen, Y. et al. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured fab in complex with antigen. J. Mol. Biol. 293, 865-881 (1999). (Pubitemid 29527672)